en

PRODUCT DETAIL

Roxiper 10 mg/4 mg/1,25 mg filmom obalené tablety

Code 8576C
MA number 58/0267/18-S
Product Form: tbl flm 90x10 mg/4 mg/1,25 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 58 - HYPOTENSIVA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10B Lipid modifying agents, combinations
C10BX HMG CoA reductase inhibitors, other combinations
C10BX13 Rosuvastatin, perindopril and indapamide
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 23.08.2018
Validity: 23.08.2023
MA renewed: Renewal application submitted
PIL: PIL_Roxiper_06/2023.pdf  
SPC: SPC_Roxiper_06/2023.pdf  
Safety feature Yes
Data update: 05.06.2019
eu-flag.png sk-flag.png